1.Acral Persistent Papular Mucinosis with Partial Response to Tacrolimus Ointment.
Ji Young JUN ; Seung Hwan OH ; Joon Ho SHIM ; Jun Hwan KIM ; Ji Hye PARK ; Dong Youn LEE
Annals of Dermatology 2016;28(4):517-519
No abstract available.
Scleromyxedema*
;
Tacrolimus*
2.Add-on Clarithromycin and Tacrolimus Treatment for Rheumatoid Arthritis.
Journal of Rheumatic Diseases 2017;24(2):123-124
No abstract available.
Arthritis, Rheumatoid*
;
Clarithromycin*
;
Tacrolimus*
3.A Rapid Effect in Childhood Granulomatous Periorificial Dermatitis with Oral Metronidazole and Topical Tacrolimus.
Yeon A NO ; Moo Yeol HYUN ; In Young OH ; Kui Young PARK ; Kapsok LI ; Beomjoon KIM ; Seongjun SEO ; Myeungnam KIM ; Changkwun HONG
Korean Journal of Dermatology 2015;53(5):405-406
No abstract available.
Dermatitis*
;
Metronidazole*
;
Tacrolimus*
4.Two Cases of Lichen Nitidus Treated with Topical 0.1% Tacrolimus.
Injung KANG ; Ki Heon JEONG ; Mu Hyoung LEE
Korean Journal of Dermatology 2014;52(9):675-676
No abstract available.
Lichen Nitidus*
;
Tacrolimus*
5.Successful Treatment with Tacrolimus in a Case of the Glucocorticoid-Dependent Recurrent Cutaneous Eosinophilic Vasculitis.
Masafumi SUGIYAMA ; Yuji NOZAKI ; Shinya IKOMA ; Koji KINOSHITA ; Masanori FUNAUCHI
Annals of Dermatology 2013;25(2):252-254
No abstract available.
Eosinophils
;
Tacrolimus
;
Vasculitis
6.The Effect of FK 506 on the Reepithelialization of Superficial Skin Wound.
Jeong Min SHIN ; Dae Kyung CHOI ; Kyung Cheol SOHN ; Young LEE ; Chang Deok KIM ; Jeung Hoon LEE ; Mi Soo CHOI ; Byung Cheol PARK
Annals of Dermatology 2017;29(5):635-637
No abstract available.
Skin*
;
Tacrolimus*
;
Wounds and Injuries*
7.Therapeutic Drug Monitoring of Tacrolimus and Sirolimus.
Sail CHUN ; Woochang LEE ; Won Ki MIN
Journal of Laboratory Medicine and Quality Assurance 2008;30(2):241-242
No abstract available.
Drug Monitoring
;
Sirolimus
;
Tacrolimus
8.Prominent Alopetic Lesions of Lichenoid Drug Eruption Treated with Topical Tacrolimus.
Annals of Dermatology 2014;26(1):141-143
No abstract available.
Drug Eruptions*
;
Tacrolimus*
9.The use of tacrolimus in the management of minimal change disease.
Kidney Research and Clinical Practice 2012;31(4):257-258
No abstract available.
Nephrosis, Lipoid
;
Tacrolimus
10.Plasma cell cheilitis in an elderly female: A case report
Maria Isabel M. Belizario, MD ; Jolene G. Dumlao, MD, FPDS ; Johannes F. Dayrit, MD
Journal of the Philippine Dermatological Society 2023;32(1):57-60
Introduction:
Plasma cell cheilitis (PCC) is a rare, chronic inflammatory dermatitis of unknown etiology. Due to the limited number of
cases reported, no guidelines have been established for its treatment. We present a case of PCC clinically similar to actinic cheilitis or mucosal lichen planus, and squamous cell carcinoma but showed response to topical tacrolimus 0.1% ointment.
Case Report:
A 62-year-old female with extreme fondness to piping hot food presented with a solitary painful ulceration with some pustules and bleeding on the lower lip with three (3) months duration. Skin punch biopsy revealed a dense band-like infiltrate of plasma cells
which is consistent with Plasma cell cheilitis. The patient was given tacrolimus 0.1% ointment and showed significant improvement after a
month of treatment.
Conclusion
PCC is a rare condition that should still be considered in patients presenting with persistent cheilitis. Clinical and histological
correlation is advised for proper management and prognostication.
cheilitis
;
plasma cell
;
tacrolimus